Clinical Trials Browser

Phase 4 × OTHER × Docetaxel × Clear all

NCT02688803 2025-12-04

OTT15-04

Phase 4 Terminated

2 enrolled 4 charts

Breast Neoplasms

NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT02484677 2023-05-26

5-FU

Phase 4 Completed

Head and Neck Neoplasms

NCT02549677 2022-10-27

ELEGANT

Phase 4 Completed

Breast Neoplasms

NCT05420454 2022-07-01

A Study for the Neoadjuvant Treatment of Breast Cancer

Phase 4 Recruiting

Breast Neoplasms

NCT05420467 2022-07-01

A Study for the Adjuvant Treatment of Breast Cancer

Phase 4 Recruiting

Breast Neoplasms

NCT04136782 2021-07-20

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Phase 4 Recruiting

Breast Neoplasms

NCT04766827 2021-02-23

Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor

Phase 4 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT02502864 2020-09-11

Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

Phase 4 Completed

9 enrolled 9 charts

Breast Neoplasms

NCT03123770 2019-04-10

ESNDBCP

Phase 4 Unknown

Breast Neoplasms

NCT03799601 2019-01-10

ALTER-L013

Phase 4 Unknown

NSCLC

NCT01660542 2016-11-01

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

Phase 4 Completed

Locally Advanced Breast Cancer

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02627248 2015-12-10

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 4 Unknown

Breast Neoplasms

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary

NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung